Details for Patent: 7,129,232
Which drugs does patent 7,129,232 protect, and when does it expire?
Patent 7,129,232 protects ZERBAXA and is included in one NDA.
Protection for ZERBAXA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-five patent family members in twenty countries.
Summary for Patent: 7,129,232
| Title: | Cephem compounds |
| Abstract: | The present invention relates to a compound of the formula [I]: wherein R1 is lower alkyl, hydroxy(lower)alkyl or halo(lower)alkyl, and R2 is hydrogen or amino protecting group, or R1 and R2 are bonded together and form lower alkylene or lower alkenylene; R3 is hydrogen or lower alkyl; R4 is R5 is carboxy or protected carboxy; and R6 is amino or protected amino, or a pharmaceutically acceptable salt thereof, a process for preparing a compound of the formula [I], and a pharmaceutical composition comprising a compound of the formula [I] in admixture with a pharmaceutically acceptable carrier. |
| Inventor(s): | Hidenori Ohki, Shinya Okuda, Toshio Yamanaka, Masaru Ohgaki, Ayako Toda, Kohji Kawabata, Satoshi Inoue, Keiji Misumi, Kenji Itoh, Kenji Satoh |
| Assignee: | Wakunaga Pharmaceutical Co Ltd , Astellas Pharma Inc |
| Application Number: | US10/695,895 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,129,232
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cubist Pharms Llc | ZERBAXA | ceftolozane sulfate; tazobactam sodium | POWDER;INTRAVENOUS | 206829-001 | Dec 19, 2014 | RX | Yes | Yes | 7,129,232*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,129,232
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Australia | 2002952355 | Oct 30, 2002 |
| Australia | 2003904813 | Sep 4, 2003 |
International Family Members for US Patent 7,129,232
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1556389 | ⤷ Start Trial | CA 2016 00004 | Denmark | ⤷ Start Trial |
| European Patent Office | 1556389 | ⤷ Start Trial | CR 2016 00004 | Denmark | ⤷ Start Trial |
| European Patent Office | 1556389 | ⤷ Start Trial | 92943 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 1556389 | ⤷ Start Trial | 300793 | Netherlands | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
